Bipolar Androgen Therapy- hear Dr. Sam Denmeade, Johns Hopkins 2/20/17 – 8pm EST

Bipolar Androgen Therapy (BAT) is one of the hottest topics in prostate cancer right now for men with metastatic disease. Counter intuitive as it is, trials have shown large doses of testosterone followed by hormone therapy or chemotherapy appear to be very effective for some men in reducing PSA – for an excellent commentary by Mike Scott on Prostate Cancer International, click here. 

Dr. Sam Denmeade at Johns Hopkins Medicine is in the forefront of this research. On Monday, February 20 at 8pm EST, Dr. Denmeade explained his research and open clinical trials on Answer Cancer Foundation’s UsTOO Hi-risk/Recurrent/Advanced Prostate Cancer Virtual Support Group meeting. 

To review Dr. Denmeade’s slide presentation, click here

​

Listen to and watch the the whole presentation here .

​

If interested in contacting Dr. Denmeade for more information on BAT trials or your suitability, please e-mail him at denmesa@jhmi.edu .